Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein –protein interaction analyses

Biomarkers are needed to inform the choice of biologic therapy in patients with asthma given the increasing number of biologics. We aimed to identify proteins associated with response to omalizumab and mepolizuma...

Source: Respiratory Research - December 6, 2023 Category: Respiratory Medicine Authors: Ayobami Akenroye, Tanawin Nopsopon, Laura Cho, Matthew Moll and Scott T. Weiss Tags: Research Source Type: research